TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer

Yu Ching Wen, Yen Nien Liu, Hsiu Lien Yeh, Wei Hao Chen, Kuo Ching Jiang, Shian Ren Lin, Jiaoti Huang, Michael Hsiao, Wei Yu Chen

研究成果: 雜誌貢獻文章同行評審

6 引文 斯高帕斯(Scopus)


Neuroendocrine differentiation (NED) is associated with WNT signaling activation and can be significantly observed after failure of androgen-deprivation therapy (ADT) for prostatic adenocarcinomas. Cytokine signaling is stimulated in NED prostate cancer; however, how ADT-upregulated WNT signaling promotes activation of cytokine signaling and contributes to NED of prostate cancer is poorly understood. In this study, we identified ADT-mediated upregulation of transcription factor 7 like 1 (TCF7L1), which increases the cytokine response and enhances NED of prostate cancer through interleukin (IL)-8/C-X-C motif chemokine receptor type 2 (CXCR2) signaling activation. ADT induced the secretion of WNT4 which upon engagement of TCF7L1 in prostate cancer cells, enhanced IL-8 and CXCR2 expressions. TCF7L1 directly binds to the regulatory sequence region of IL-8 and CXCR2 through WNT4 activation, thus upregulating IL-8/CXCR2 signaling-driven NED and cell motility. Analysis of prostate tissue samples collected from small-cell neuroendocrine prostate cancer (SCPC) and castration-resistant prostate cancer (CRPC) tumors showed an increased intensity of nuclear TCF7L1 associated with CXCR2. Our results suggest that induction of WNT4/TCF7L1 results in increased NED and malignancy in prostate cancer that is linked to dysregulation of androgen receptor signaling and activation of the IL-8/CXCR2 pathway.
出版狀態已發佈 - 11月 2021

ASJC Scopus subject areas

  • 分子生物學
  • 癌症研究


深入研究「TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer」主題。共同形成了獨特的指紋。